Observational studyJournal of managed care & specialty pharmacy2023

Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodies.

Todd J Schwedt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.